Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayes1, X Rabasseda, J R Prous

  • 1Prous Science, Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|November 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This study provides a comprehensive list of novel therapeutic agents, including small molecules, biologics, and radiopharmaceuticals, for various diseases. The findings highlight advancements in drug discovery and development across multiple medical fields.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Discovery and Development
  • Biotechnology

Context:

  • The landscape of therapeutic agents is rapidly evolving, with continuous innovation in drug discovery.
  • A wide array of novel compounds, including small molecules, biologics, and radiopharmaceuticals, are under investigation.
  • These agents target diverse pathological pathways and disease indications.

Purpose:

  • To catalog and present a broad spectrum of emerging therapeutic agents.
  • To provide an overview of the current pipeline of investigational drugs.
  • To serve as a reference for researchers and clinicians in the field of pharmacotherapy.

Summary:

  • The abstract lists numerous novel therapeutic agents, encompassing small molecules like (-)-Epigallocatechin gallate and Abiraterone acetate, biologics such as Adalimumab and Nivolumab, and radiopharmaceuticals like Yttrium 90 (90Y) ibritumomab tiuxetan.

Related Experiment Videos

  • These agents represent diverse therapeutic classes and are being developed for a wide range of conditions, including cancer, autoimmune diseases, and infectious diseases.
  • The compilation reflects the ongoing efforts in medicinal chemistry, molecular biology, and nuclear medicine to address unmet medical needs.

    • Impact:

    • Facilitates a broader understanding of the current therapeutic development pipeline.
    • Supports strategic decision-making in pharmaceutical research and investment.
    • Accelerates the identification of potential therapeutic candidates for specific disease areas.